151 related articles for article (PubMed ID: 33639277)
1. Recombinant expression, purification and characterization of human soluble tumor necrosis factor receptor 2.
Li A; Sun K; Wang J; Wang S; Zhao X; Liu R; Lu Y
Protein Expr Purif; 2021 Jun; 182():105857. PubMed ID: 33639277
[TBL] [Abstract][Full Text] [Related]
2. Recombinant expression, purification and bioactivity characterization of extracellular domain of human tumor necrosis factor receptor 1.
Zhang C; Li A; Wang R; Cao Y; Jiang H; Ouyang S; Ma X; Lu Y
Protein Expr Purif; 2019 Mar; 155():21-26. PubMed ID: 30414969
[TBL] [Abstract][Full Text] [Related]
3. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
Front Immunol; 2018; 9():583. PubMed ID: 29623079
[TBL] [Abstract][Full Text] [Related]
4. TNFR2: A Novel Target for Cancer Immunotherapy.
Vanamee ÉS; Faustman DL
Trends Mol Med; 2017 Nov; 23(11):1037-1046. PubMed ID: 29032004
[TBL] [Abstract][Full Text] [Related]
5. Increased Regulatory T Cells in Peripheral Blood of Acute Myeloid Leukemia Patients Rely on Tumor Necrosis Factor (TNF)-α-TNF Receptor-2 Pathway.
Wang M; Zhang C; Tian T; Zhang T; Wang R; Han F; Zhong C; Hua M; Ma D
Front Immunol; 2018; 9():1274. PubMed ID: 29922294
[TBL] [Abstract][Full Text] [Related]
6. Effects of bovine tumor necrosis factor alpha decoy receptors on cell death and inflammatory cytokine kinetics: potential for bovine inflammation therapy.
Fujisawa S; Konnai S; Okagawa T; Maekawa N; Tanaka A; Suzuki Y; Murata S; Ohashi K
BMC Vet Res; 2019 Feb; 15(1):68. PubMed ID: 30819151
[TBL] [Abstract][Full Text] [Related]
7. Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated Tregs.
Torrey H; Butterworth J; Mera T; Okubo Y; Wang L; Baum D; Defusco A; Plager S; Warden S; Huang D; Vanamee E; Foster R; Faustman DL
Sci Signal; 2017 Jan; 10(462):. PubMed ID: 28096513
[TBL] [Abstract][Full Text] [Related]
8. Optimization of culture conditions for high-level expression of soluble and active tumor necrosis factor-α in E. coli.
Damough S; Sabzalinezhad M; Talebkhan Y; Nematollahi L; Bayat E; Torkashvand F; Adeli A; Jahandar H; Barkhordari F; Mahboudi F
Protein Expr Purif; 2021 Mar; 179():105805. PubMed ID: 33290843
[TBL] [Abstract][Full Text] [Related]
9. Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.
Lang I; Füllsack S; Wajant H
Front Immunol; 2018; 9():793. PubMed ID: 29740434
[TBL] [Abstract][Full Text] [Related]
10. Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.
Verwoerd A; Hijdra D; Vorselaars AD; Crommelin HA; van Moorsel CH; Grutters JC; Claessen AM
Clin Exp Immunol; 2016 Aug; 185(2):263-70. PubMed ID: 27158798
[TBL] [Abstract][Full Text] [Related]
11. Identification and functional characterization of grass carp (Ctenopharyngodon idella) tumor necrosis factor receptor 2 and its soluble form with potentiality for targeting inflammation.
Zhang S; Wang X; Li C; Feng S; Zhang A; Yang K; Zhou H
Fish Shellfish Immunol; 2019 Mar; 86():393-402. PubMed ID: 30502465
[TBL] [Abstract][Full Text] [Related]
12. Refolding and purification of recombinant human (Pro)renin receptor from Escherichia coli by ion exchange chromatography.
Wang F; Guo J; Bai Q; Wang L
Biotechnol Prog; 2014; 30(4):864-71. PubMed ID: 24723509
[TBL] [Abstract][Full Text] [Related]
13. Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity.
Yang M; Tran L; Torrey H; Song Y; Perkins H; Case K; Zheng H; Takahashi H; Kuhtreiber WM; Faustman DL
J Leukoc Biol; 2020 Jun; 107(6):971-980. PubMed ID: 32202358
[TBL] [Abstract][Full Text] [Related]
14. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
Cao P; Mei JJ; Diao ZY; Zhang Sq
Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
[TBL] [Abstract][Full Text] [Related]
15. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
Islam MS; Yang Y; Chen X
Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
[TBL] [Abstract][Full Text] [Related]
16. TNFR2-expressing CD4
He J; Li R; Chen Y; Hu Y; Chen X
Prog Mol Biol Transl Sci; 2019; 164():101-117. PubMed ID: 31383403
[TBL] [Abstract][Full Text] [Related]
17. TNFR2 blockade alone or in combination with PD-1 blockade shows therapeutic efficacy in murine cancer models.
Case K; Tran L; Yang M; Zheng H; Kuhtreiber WM; Faustman DL
J Leukoc Biol; 2020 Jun; 107(6):981-991. PubMed ID: 32449229
[TBL] [Abstract][Full Text] [Related]
18. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
[TBL] [Abstract][Full Text] [Related]
19. Fed-batch production of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in soluble form in Escherichia coli and its purification and characterization.
Li P; Gu Q; Wu X
Protein Expr Purif; 2016 Oct; 126():115-121. PubMed ID: 27335160
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
Zou H; Li R; Hu H; Hu Y; Chen X
Front Immunol; 2018; 9():594. PubMed ID: 29632537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
